MD Anderson Cancer Center Selects MedQuist Speech and Natural Language Understanding Platform for Enterprise-level Deployment

MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced today that The University of Texas MD Anderson Cancer Center of Houston, Texas, has selected the company's cloud-based Speech Understanding™ and Natural Language Understanding (NLU) platform from M*Modal to become an integral part of MD Anderson's proprietary ClinicStation electronic medical record (EMR) system and RadStation radiology solution.

Through the collaboration between M*Modal technology and MD Anderson, all physicians throughout the enterprise will efficiently capture the patient story and transform it into structured and encoded differentiated information. Integrated with the structured data captured through the EMR, this new level of information produces comprehensive and highly contextual intelligence that contributes to effective clinical decision making and actions in the complex cases faced by MD Anderson, one of the world's premier centers devoted exclusively to cancer patient care, research, education and prevention.

The M*Modal clinical content discovery solutions will be utilized to facilitate the healthcare organization's extensive analytical and research workflows. With the company's cloud-based natural language understanding platform, users can search and interrogate massive volumes of unstructured and structured data to uncover content-rich information that can be used for a wide variety of critical clinical and administrative needs.

"While capturing meaningful information from our narrative documents is a critical part of our EMR strategy, it also enhances our overall clinical informatics and research environment, to which we are highly committed," said Lynn Vogel, CIO of MD Anderson. "After a comprehensive and highly competitive selection process, we ultimately viewed M*Modal as the optimal partner for realizing our vision."

Compared with first generation speech recognition technologies, M*Modal's Speech Understanding natively combines advanced speech and language understanding. The approach leads to superior speech recognition results while automatically turning the narrative into structured and encoded information -- not simply tagged data elements but also highly meaningful information that drives medical decision making and action. The company's natural language understanding supports robust clinical content services that permit search and discovery across massive amounts of narrative and structured information.

"With the integration of M*Modal's unique open platform, we will be able to satisfy two key objectives," added Chuck Suitor, Director, EMR Development and Support, MD Anderson. "First, we can accommodate the varied documentation styles and needs of our caregivers for maximum efficiency. Secondly, we can obtain the critical intelligence we need to promote the care standard for which we are recognized, regardless of the method of documentation of physicians."

"We are pleased to be selected as a strategic partner with such an acknowledged leader in clinical informatics as MD Anderson," noted Vern Davenport, Chairman and CEO of MedQuist Holdings. "We share a joint vision with MD Anderson of leveraging the narrative and unstructured patient information to provide deep insight into clinical information. In turn, this differentiated information will enhance care delivery and provide complete views of the patient story contained in ClinicStation and RadStation."

About The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For eight of the past 10 years, including 2011, MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.

About MedQuist

MedQuist is a leading provider of clinical narrative capture services, Speech Understanding technology from M*Modal and clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms and global network of medical editors – help healthcare facilities facilitate adoption of electronic health records (EHR), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.medquist.com.

The MedQuist Holdings Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10083

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Thomas Mitchell
         Director of Marketing
         615-798-6630
         [e-mail]